News
A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs
28 Jan 2026
en
Date: 9/16-17
Location: Hyatt Regency La Jolla, San Diego
Attendee:
Xiaoxia Chen, Ph.D., Chief Technology Officer
Chris Heard, BD Director
Booth: No.9
Link: https://ddfsummit.com/DDF2024/en/page/home
Ready for an evening of unscripted connection?
Please complete the form to register for our San Diego Biotech and Pharma R&D social. Note: Registration is subject to review. You will receive a formal confirmation email once your attendance is approved.
By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your registration. The information you submit will be governed by our Privacy Policy.
_.webp "A Significant Step Toward Greater Clarity in Polymorph Control for Innovative Drugs")
Subscribe to be the first to get the updates!
